Meredith McKean, MD, MPH, the associate director of the Sarah Cannon Research Institute’s Melanoma and Skin Cancer Research Program at Tennessee Oncology, discussed new melanoma studies and treatment developments.
2023
Gut microbiome changes seen in later-stage melanoma
Gut microbiome analysis found differences in those with early- and late-stage melanoma compared with controls.
Everyday chemicals linked to increased cancer risk, especially in women
Multiple variables impact prostate and breast cancer incidence, including genetic heredity as well as environmental and societal influences.
Swedish Melanoma Detection Device To Be Piloted at Dallas-Area Bare Dermatology Clinics
Doctors can often identify signs of a melanoma through a visual examination of a patient’s skin, by using a dermoscope or other tools.